ResearcherUniversity of RochesterActive in the last 2 years
Jian Ye
Matched on ORCID iD 0000-0002-6955-9262; OpenAlex author ID A5100370190. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 6
- Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.ijrobp.2025.06.3853↗
- Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. Co-author DOI 10.1136/jitc-2024-010820↗
- CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models. Co-author DOI 10.1136/jitc-2023-006842↗
- Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer. Co-author DOI 10.1136/jitc-2022-004784↗
- Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy. Co-author DOI 10.1158/1078-0432.ccr-21-2495↗
- Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1080/08820139.2020.1765795↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David C. Linehan · 6 shared papers, 2020–2026 · strength 0.97
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
- Paper CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2023-006842↗
- Bradley N. Mills · 5 shared papers, 2020–2026 · strength 0.81
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
- Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
- Scott A. Gerber · 4 shared papers, 2022–2026 · strength 0.73
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
- Paper CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2023-006842↗
- Joseph D. Murphy · 4 shared papers, 2020–2026 · strength 0.61
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
- Paper Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy. DOI 10.1158/1078-0432.ccr-21-2495↗
- Angela L. Hughson · 3 shared papers, 2023–2026 · strength 0.60
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
- Paper CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2023-006842↗
- Tara G Vrooman · 3 shared papers, 2022–2025 · strength 0.49
- Paper Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2024-010820↗
- Paper CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models. DOI 10.1136/jitc-2023-006842↗
- Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
- Haoming Qiu · 2 shared papers, 2022–2026 · strength 0.38
- Paper Improving Stereotactic Body Radiation Therapy by Rewiring Immunosuppressive Neutrophils in Murine Pancreatic Ductal Ade… DOI 10.1016/j.ijrobp.2025.06.3853↗
- Paper Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy. DOI 10.1158/1078-0432.ccr-21-2495↗
- Booyeon Julia Han · 2 shared papers, 2020–2022 · strength 0.24
- Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
- Paper Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinom… DOI 10.1080/08820139.2020.1765795↗
- Scott A. Gerber · 2 shared papers, 2020–2022 · strength 0.24
- Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
- Paper Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinom… DOI 10.1080/08820139.2020.1765795↗
- Laura Maria Calvi · 1 shared paper, 2025 · strength 0.19
- Alan W. Katz · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.